CNTB · Connect Biopharma Holdings Ltd
$2.55
+0.01 (+0.39%)
At close · Aug 14
Market Cap
$160.58M
Shares
62.97M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.55
Open$2.54
Day$2.36–2.57
52W close$1.32–3.69
Avg vol 30d467K
Short int2.1M · 3.3% float · 8.0d
Short vol45%
Last earningsJun 30, 2022
DataMar 2021–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Very Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+5%
above
Price vs 50-day avg
+15%
above
RSI (14)
66
neutral
MACD trend
Positive
52-week position
52%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+7%
trailing
6-month return
−2%
trailing
YTD return
−10%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+38% holders QoQ · +24 funds added
Insider flow
Accumulating
Net +$371.6K over 90 days · 0% sells
Short interest
Falling
3.27% of float · ▼ -0.1% MoM · 8.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
55 holders — near 1-yr high, broad support
Squeeze score
66
elevated · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−257%
Y/Y
Free cash flow
$-51.6M
Balance sheet
$38.3M
net cash
Quant / Vol
risk profile
Volatility
93%
annualized · 1-yr
Max drawdown
−47%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+5%
Bullish
Price vs 50-day avg
+15%
Bullish
RSI (14)
66
Neutral
MACD trend
Positive
Bullish
52-week position
52%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+38% holders QoQ · +24 funds added
Insider flow
Accumulating
Net +$371.6K over 90 days · 0% sells
Short interest
Falling
3.27% of float · ▼ -0.1% MoM · 8.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
55 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $3 · 52%
Range high $4
vs 200-day avg +5%
vs 50-day avg +15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNTB
this stock
Connect Biopharma Holdings Ltd
|
$160.58M | -9.6% | -99.8% | — | 3.3% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
55
- % held
- 22.1%
- Net QoQ
- +870.3K sh
- Top holder
- Ikarian Capital, LLC
Held
Float
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNTB | +15.7% | +7.1% | -1.9% | +26.2% | -9.6% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +15.3% | +2.7% | -15.7% | +22.3% | -23.4% |
Key facts
CIK
1835268
CUSIP
G23549101
13F (30d)
53 filings
53 filers
Visit website
Investor relations